World's Best Scientists 2026 revealed!
Heather A. Wakelee

Heather A. Wakelee

D-Index & Metrics

Medicine

D-Index
91
Citations
35558
World Ranking
11635
National Ranking
5967

Overview

Heather A. Wakelee is affiliated with Stanford University in the United States and has made significant contributions primarily in the field of Medicine with a strong focus on Pulmonary and Respiratory Medicine and Oncology. Their research covers various subfields, including Cancer Research, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The main topics in their body of work include:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Radiomics and Machine Learning in Medical Imaging

Wakelee has an extensive publication record in well-known outlets. Frequent publication venues for their work include:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Clinical Lung Cancer
  • JTO Clinical and Research Reports
  • Annals of Oncology

The scientist has co-authored with multiple researchers repeatedly, including Joel W. Neal, Sukhmani K. Padda, Jacqueline V. Aredo, Kavitha Ramchandran, and Millie Das.

Among recent publications associated with or closely related to their research, the following notable papers stand out:

  • Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer, 2023, New England Journal of Medicine
  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial, 2021, The Lancet
  • Integrating genomic features for non-invasive early lung cancer detection, 2020, Nature
  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study, 2020, The Lancet Oncology
  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer, 2021, Journal of Thoracic Oncology

Best Publications

  • An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

    Aaron M Newman;Scott V Bratman;Jacqueline To;Jacob F Wynne

  • Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

    J. Mazieres;A. Drilon;A. Lusque;L. Mhanna

  • Integrated digital error suppression for improved detection of circulating tumor DNA

    Aaron M Newman;Alexander F Lovejoy;Daniel M Klass;David M Kurtz

  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.

    Enriqueta Felip;Nasser Altorki;Caicun Zhou;Tibor Csőszi

  • Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

    Aadel A. Chaudhuri;Jacob J. Chabon;Alexander F. Lovejoy;Aaron M. Newman

  • Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

    Lecia V. Sequist;Jean Charles Soria;Jonathan W. Goldman;Heather A. Wakelee

  • Lung Cancer Incidence in Never Smokers

    Heather A. Wakelee;Ellen T. Chang;Scarlett L. Gomez;Theresa H. M. Keegan

  • American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

    Vicki Leigh Keedy;Sarah Temin;Mark R. Somerfield;Mary Beth Beasley

  • Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

    Jacob J. Chabon;Andrew D. Simmons;Alexander F. Lovejoy;Mohammad S. Esfahani

  • Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

    Christian Rolfo;Philip C. Mack;Giorgio V. Scagliotti;Paul Baas

  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

    Marina Chiara Garassino;Jennifer G. Whisenant;Li Ching Huang;Annalisa Trama

  • First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.

    Branimir I. Sikic;Nehal Lakhani;Amita Patnaik;Sumit A. Shah

  • Integrating genomic features for non-invasive early lung cancer detection

    Jacob J. Chabon;Emily G. Hamilton;David M. Kurtz;Mohammad S. Esfahani

  • Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor

    Zofia Piotrowska;Matthew J. Niederst;Chris A. Karlovich;Heather A. Wakelee

  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Christian Rolfo;Philip Mack;Giorgio V. Scagliotti;Charu Aggarwal

  • Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2

    Lucio Crinò;Myung Ju Ahn;Filippo De Marinis;Harry J. M. Groen

  • Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

    Rowan T. Chlebowski;Ann G. Schwartz;Heather Wakelee;Garnet L. Anderson

  • EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

    Nicolas Marcoux;Scott N. Gettinger;Grainne O’Kane;Kathryn C. Arbour

  • Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry

    Oliver Gautschi;Julie Milia;Thomas Filleron;Juergen Wolf

  • An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers

    Quynh-Thu Le;Eunice Chen;Ali Salim;Hongbin Cao

Frequent Co-Authors

Maximilian Diehn
Maximilian Diehn Stanford University
Leora Horn
Leora Horn Vanderbilt University Medical Center
Lecia V. Sequist
Lecia V. Sequist Harvard University
Ash A. Alizadeh
Ash A. Alizadeh Stanford University
David R. Gandara
David R. Gandara University of California, Davis
D. Ross Camidge
D. Ross Camidge University of Colorado Anschutz Medical Campus
Suresh S. Ramalingam
Suresh S. Ramalingam Emory University
Tony Mok
Tony Mok Chinese University of Hong Kong
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always mean becoming a doctor. There are several flexible and accessible online programs for students interested in healthcare careers. For those without a nursing background, online bsn programs for non nurses offer a pathway to enter the nursing field efficiently while accommodating busy schedules.

If you prefer working behind the scenes in healthcare, consider exploring online medical billing and coding with financial aid. This option is great for students seeking administrative roles and the flexibility of remote work.

Aspiring practical nurses can benefit from programs like an lpn program no entrance exam, which removes common barriers and accelerates entry into the workforce.

For those aiming for leadership or management positions, an healthcare administration accelerated degree provides a fast track to a wide range of roles in hospital or clinical management, aligning with the industry's growing demand.

Best Scientists Citing Heather A. Wakelee

Trending Scientists

Recently Published Articles